Cardiovascular Risk Assessment Across the Female Life Course: Key Time Windows for Earlier Identification and Prevention
Cardiovascular disease remains the leading cause of death in women, yet risk is frequently underestimated, particularly during early and middle adulthood. A life-course perspective may identify periods in which female-specific factors reveal or accelerate cardiovascular vulnerability. This narrative review examines cardiovascular risk across adolescence, reproductive life, pregnancy, the postpartum period, menopause, and older age. Relevant literature was identified through a targeted PubMed search, supplemented by major international guidelines and reference screening. The review addresses reproductive and pregnancy-related risk factors, female-predominant conditions, limitations of current prediction models, and the potential contribution of biomarkers and imaging, including coronary artery calcium and breast arterial calcification. Cardiovascular prevention in women should move beyond isolated 10-year risk estimates towards longitudinal assessment that incorporates reproductive history and female-specific risk modifiers. Pregnancy and the postpartum period are underused opportunities for early prevention, whereas selected imaging tools may improve risk classification when conventional scores are uncertain. Future progress will require structured follow-up pathways, multidisciplinary care, systematic capture of female-specific risk factors, and prediction models validated in diverse female populations. We distinguish epidemiological associations from independently validated risk prediction and from interventions with demonstrated clinical benefit, and propose a staged, guideline-anchored pathway for reassessment at key life transitions.
Authors
- Paolo Calabrò (ORCID: https://orcid.org/0000-0002-5018-830X)
- Stefano Cacciatore (ORCID: https://orcid.org/0000-0001-7504-3775)
- Michele Golino (ORCID: https://orcid.org/0000-0003-0141-0127)
- Felice Gragnano (ORCID: https://orcid.org/0000-0002-6943-278X)
- Stefano Figliozzi (ORCID: https://orcid.org/0000-0003-2991-1548)
- Stéphane Manzo‐Silberman (ORCID: https://orcid.org/0000-0002-0703-1331)
- Mamas A. Mamas (ORCID: https://orcid.org/0000-0001-9241-8890)
- Elad Asher (ORCID: https://orcid.org/0000-0003-3381-605X)
- Giuseppe Andò (ORCID: https://orcid.org/0000-0001-5552-6382)
- Atul Pathak (ORCID: https://orcid.org/0000-0001-6151-0096)
- Marco Bernardi (ORCID: https://orcid.org/0000-0001-9269-8829)
- Marta Kałużna‐Oleksy (ORCID: https://orcid.org/0000-0003-4048-6247)
- Nuntakorn Thongtang (ORCID: https://orcid.org/0000-0002-8810-5397)
- Dan Atar (ORCID: https://orcid.org/0000-0003-1513-8793)
- Pierre François Sabouret (ORCID: https://orcid.org/0000-0002-0243-3673)
- Eva Gerdts (ORCID: https://orcid.org/0000-0003-4109-2311)
- Domenico Mario Giamundo (ORCID: https://orcid.org/0009-0000-2161-3066)
- Lorenzo Cambini (ORCID: https://orcid.org/0009-0007-1637-2924)
- Yara Antakly Hanon (ORCID: https://orcid.org/0000-0003-0753-8121)
Institutions
- University of Messina (IT)
- Poznan University of Medical Sciences (PL)
- Oslo University Hospital (NO)
- Siriraj Hospital (TH)
- Humanitas University (IT)
- Inserm (FR)
- Hebrew University of Jerusalem (IL)
- University of Campania "Luigi Vanvitelli" (IT)
- Mahidol University (TH)
- Shaare Zedek Medical Center (IL)
- Bikur Cholim Hospital (IL)
- University of Florida (US)
- Jacksonville University (US)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Luxembourg Institute of Health (LU)
- Hôpital Saint Joseph (FR)
- Pitié-Salpêtrière Hospital (FR)
- Laboratoire National de Santé (LU)
- Policlinico Casilino (IT)
- Ospedale Sant'Anna (IT)
- University of Bergen (NO)
- Keele University (GB)
- Sapienza University of Rome (IT)
- Florida College (US)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/jcdd13110601
- Primary Topic
- Health Promotion and Cardiovascular Prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00